Aurora shuttering Reliva CBD unit as exports help narrow loss
A significant jump in plant-propagation sales and medical marijuana exports helped Canadian licensed producer Aurora Cannabis narrow its loss in the first quarter of fiscal year 2024 to 28.3 million Canadian dollars ($20 million).